Fecal microbiota transplantation for recurrent Clostridium difficile infection: The patient experience

American Journal of Infection Control

Volumn 44, Issue 5, 2016, Pages 554-559

  Pakyz, Amy L ^a   Moczygemba, Leticia R ^a   Vanderwielen, Lynn M ^b   Edmond, Michael B ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

fecal bacteriotherapy; Qualitative study

Indexed keywords

FIDAXOMICIN; METRONIDAZOLE; VANCOMYCIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DEPRESSION; DRUG COST; EMPOWERMENT; FEAR; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HOPELESSNESS; HUMAN; INFORMATION SEEKING; MALE; MIDDLE AGED; NONHUMAN; PATIENT ADVOCACY; PATIENT CODING; PERSONAL EXPERIENCE; QUALITATIVE RESEARCH; QUALITY OF LIFE; RECURRENT INFECTION; SEMI STRUCTURED INTERVIEW; SOCIAL SUPPORT; TELEPHONE INTERVIEW; WEIGHT REDUCTION; CLOSTRIDIUM INFECTION; INTERVIEW; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATIENT SATISFACTION; PEPTOCLOSTRIDIUM DIFFICILE; SECONDARY PREVENTION; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; SECONDARY PREVENTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84961219065     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2016.01.018     Document Type: Article

References (29)

1. E.R. Dubberke, P. Carling, R. Carrico, C.J. Donskey, V.G. Loo, L.C. McDonald, and et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update Infect Control Hosp Epidemiol 35 2014 628 645
2. S.S. Magill, J.R. Edwards, W. Bamberg, Z.G. Beldavs, G. Dumyati, M.A. Kainer, and et al. Multistate point-prevalence survey of health care-associated infections N Engl J Med 370 2014 1198 1208
3. F.C. Lessa, Mu Y., W.M. Bamberg, Z.G. Beldavs, G.K. Dumyati, J.R. Dunn, and et al. Burden of Clostridium difficile infection in the United States N Engl J Med 372 2015 825 834
4. I. See, Mu Y., J. Cohen, Z.G. Beldavs, L.G. Winston, G. Dumyati, and et al. NAP1 strain type predicts outcomes from Clostridium difficile infection Clin Infect Dis 58 2014 1394 1400
5. J. Pepin, M.E. Alary, L. Valiquette, E. Raiche, J. Ruel, K. Fulop, and et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada Clin Infect Dis 40 2005 1591 1597
6. F.A. Zar, S.R. Bakkanagari, K.M. Moorthi, and M.B. Davis A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity Clin Infect Dis 45 2007 302 307
7. L.V. McFarland, G.W. Elmer, and C.M. Surawicz Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease Am J Gastroenterol 97 2002 1769 1775
8. M.P. Bauer, D.W. Notermans, B.H. van Benthem, J.S. Brazier, M.H. Wilcox, M. Rupnik, and et al. Clostridium difficile infection in Europe: a hospital-based survey Lancet 377 2011 63 73
9. J.S. Bakken, T. Borody, L.J. Brandt, J.V. Brill, D.C. Demarco, M.A. Franzos, and et al. Treating Clostridium difficile infection with fecal microbiota transplantation Clin Gastroenterol Hepatol 9 2011 1044 1049
10. I. Youngster, G.H. Russell, C. Pindar, T. Ziv-Baran, J. Sauk, and E.L. Hohmann Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection JAMA 312 2014 772 778
11. B.E. Hirsch, N. Saraiya, K. Poeth, R.M. Schwartz, M.E. Epstein, and G. Honig Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent C. difficile infection BMC Infect Dis 15 2015 191
12. L.J. Brandt, O.C. Aroniadis, M. Mellow, A. Kanatzar, C. Kelly, T. Park, and et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection Am J Gastroenterol 107 2012 1079 1087
13. E. van Nood, A. Vrieze, M. Nieuwdorp, S. Fuentes, E.G. Zoetendal, W.M. de Vos, and et al. Duodenal infusion of donor feces for recurrent Clostridium difficile N Engl J Med 368 2013 407 415
14. J.S. Zipursky, T.I. Sidorsky, C.A. Freedman, M.N. Sidorsky, and K.B. Kirkland Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection Clin Infect Dis 55 2012 1652 1658
15. M.A. Khan, A.A. Sofi, U. Ahmad, O. Alaradi, A.R. Khan, T. Hammad, and et al. Efficacy and safety of, and patient satisfaction with, colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection Can J Gastroenterol Hepatol 28 2014 434 438
16. J.S. Bakken, P.M. Polgreen, S.E. Beekmann, F.X. Riedo, and J.A. Streit Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians Anaerobe 24 2013 20 24
17. J.S. Zipursky, T.I. Sidorsky, C.A. Freedman, M.N. Sidorsky, and K.B. Kirkland Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection Can J Gastroenterol Hepatol 28 2014 319 324
18. I. Guillemin, A. Marrel, J. Lambert, A. Beriot-Mathiot, C. Doucet, O. Kazoglou, and et al. Patients' experience and perception of hospital-treated Clostridium difficile infections: a qualitative study Patient 7 2014 97 105
19. M.Q. Patton Qualitative research and evaluation methods 3rd ed 2002 Sage Publications Thousand Oaks (CA)
20. J.H. Hibbard, J. Stockard, E.R. Mahoney, and M. Tusler Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers Health Serv Res 39 2004 1005 1026
21. B. Mole FDA gets to grips with faeces Nature 498 2013 147 148
22. M. Madeo, and M. Boyack Using the lived experiences of patients with Clostridium difficile infection to improve care Nurs Times 106 2010 10 13
23. J. Aas, C.E. Gessert, and J.S. Bakken Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube Clin Infect Dis 36 2003 580 585
24. J.H. Hibbard Using systematic measurement to target consumer activation strategies Med Care Res Rev 66 1 Suppl 2009 9S 27S
25. M. Ratner Fecal transplantation poses dilemma for FDA Nat Biotechnol 32 2014 401 402
26. C.M. Surawicz, L.J. Brandt, D.G. Binion, A.N. Ananthakrishnan, S.R. Curry, P.H. Gilligan, and et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections Am J Gastroenterol 108 2013 478 498
27. T.D. Lawley, S. Clare, A.W. Walker, M.D. Stares, T.R. Connor, C. Raisen, and et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice PLoS Pathog 8 2012 e1002995 10.1371/journal.ppat.1002995
28. E.O. Petrof, G.B. Gloor, S.J. Vanner, S.J. Weese, D. Carter, M.C. Daigneault, and et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: "RePOOPulating" the gut Microbiome 1 2013 3
29. D.N. Gerding, T. Meyer, C. Lee, S.H. Cohen, U.K. Murthy, A. Poirier, and et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial JAMA 313 2015 1719 1727